LNA043 - modified, recombinant human angiopoietin-like 3 (ANGPTL3) protein ⭐️proof of concept trial on patients with articular cartilage lesions ⭐️regeneration of damaged cartilage ⭐️treatment effect in cartilage volume ⭐️phase IIb pending Abs#POS0277 #EULAR2021 @RheumNow